These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 24142575)
1. Prognostic impact of p300 expression in patients with colorectal cancer. Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK J Surg Oncol; 2013 Nov; 108(6):374-7. PubMed ID: 24142575 [TBL] [Abstract][Full Text] [Related]
2. High expression of the transcriptional co-activator p300 predicts poor survival in resectable non-small cell lung cancers. Hou X; Li Y; Luo RZ; Fu JH; He JH; Zhang LJ; Yang HX Eur J Surg Oncol; 2012 Jun; 38(6):523-30. PubMed ID: 22440742 [TBL] [Abstract][Full Text] [Related]
3. Thymidylate synthase and cyclin D1 protein expression in lymph node negative colorectal cancer: role as prognostic factors? Formentini A; Henne-Bruns D; Kornmann M Hepatogastroenterology; 2012 Sep; 59(118):1859-64. PubMed ID: 22819905 [TBL] [Abstract][Full Text] [Related]
4. Metastatic potential in T1 and T2 colorectal cancer. Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of integrin αv correlates with poor prognosis in colorectal cancer. Ha SY; Shin J; Kim JH; Kang MS; Yoo HY; Kim HH; Um SH; Kim SH J Clin Pathol; 2014 Jul; 67(7):576-81. PubMed ID: 24695839 [TBL] [Abstract][Full Text] [Related]
6. Expression of HDAC1 and CBP/p300 in human colorectal carcinomas. Ishihama K; Yamakawa M; Semba S; Takeda H; Kawata S; Kimura S; Kimura W J Clin Pathol; 2007 Nov; 60(11):1205-10. PubMed ID: 17720775 [TBL] [Abstract][Full Text] [Related]
7. Expression of standard CD44 in human colorectal carcinoma: association with prognosis. Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367 [TBL] [Abstract][Full Text] [Related]
8. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
9. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen. Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063 [TBL] [Abstract][Full Text] [Related]
10. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma. Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node ratio in stage III colorectal cancer. Wong KP; Poon JT; Fan JK; Law WL Colorectal Dis; 2011 Oct; 13(10):1116-22. PubMed ID: 20874800 [TBL] [Abstract][Full Text] [Related]
12. Expression of annexin a5 is associated with higher tumor stage and poor prognosis in colorectal adenocarcinomas. Xue G; Hao LQ; Ding FX; Mei Q; Huang JJ; Fu CG; Yan HL; Sun SH J Clin Gastroenterol; 2009 Oct; 43(9):831-7. PubMed ID: 19461527 [TBL] [Abstract][Full Text] [Related]
13. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer. Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222 [TBL] [Abstract][Full Text] [Related]
14. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer. Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573 [TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic and prognostic relevance of ARID1A protein loss in colorectal cancer. Wei XL; Wang DS; Xi SY; Wu WJ; Chen DL; Zeng ZL; Wang RY; Huang YX; Jin Y; Wang F; Qiu MZ; Luo HY; Zhang DS; Xu RH World J Gastroenterol; 2014 Dec; 20(48):18404-12. PubMed ID: 25561809 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer. Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329 [TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709 [TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Li M; Li JY; Zhao AL; Gu J Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831 [TBL] [Abstract][Full Text] [Related]
20. Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Messerini L; Cianchi F; Cortesini C; Comin CE Hum Pathol; 2006 Oct; 37(10):1259-67. PubMed ID: 16949928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]